Skip to main content
Log in

Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Extended-spectrum β-lactamase (ESBL)-producing bacteria are infrequent pathogens of community-acquired (CA) urinary tract infections (UTIs) in children. The aim of this study was to assess the frequency of and identify risk factors for CA-UTIs due to ESBL-producing microorganisms (CA-ESBL-UTI).

Methods

The medical records of all children diagnosed with CA-ESBL-UTI at our medical center between 2003 and 2013 were reviewed. Patients with non-ESBL-UTIs during the same period were included as controls.

Results

Eighty cases of CA-ESBL-UTI were identified. The incidence of ESBL-UTI increased from 2 to 3.8% during the study period. Compared to children with non-ESBL-UTI, those with ESBL were more likely to be of Arab descent, to have underlying medical conditions, to have received antibiotics in the month prior to the UTI and to have been previously hospitalized. The mean duration of hospitalization for patients with an ESBL-UTI was significantly longer than that for patients with a non-ESBL UTI (3.6 vs. 2 days; P = 0.01). In multivariate analysis, Arab ethnicity [odds ratio (OR) 6.1; 95 % confidence interval (CI) 2.7–13.6] and recent antibiotic treatment (OR 4.0; 95 % CI 1.6–10.4) were risk factors for CA-ESBL-UTI.

Conclusions

The incidence of CA-ESBL-UTI is rising. The empiric treatment for suspected UTI in children who had been previously hospitalized and who had received antibiotics in the last month should cover ESBL-producing bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Fan NC, Chen HH, Chen CL, Ou LS, Lin TY, Tsai MH, Chiu CH (2013) Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. doi:10.1016/j.jmii.2013.05.006

    Google Scholar 

  2. Chen PC, Chang LY, Lu CY, Shao PL, Tsai IJ, Tsau YK, Lee PI, Chen JM, Hsueh PR, Huang LM (2013) Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J Microbiol Immunol Infect. doi:10.1016/j.jmii.2013.07.011

    Google Scholar 

  3. Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, Ozen S, Bakkaloglu A, Gur D (2010) Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 25:919–925

    Article  PubMed  Google Scholar 

  4. Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013) Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163:1417–1421

    Article  PubMed  Google Scholar 

  5. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:595–610

    Article  PubMed  Google Scholar 

  6. Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. CLSI document M100-S17. CLSI, Wayne

  7. Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8:1

    Article  PubMed Central  PubMed  Google Scholar 

  8. U.S. Federal Drug Administration (2004) Cipro (ciprofloxacin hydrochloride) (package insert). Bayer Pharmaceutical Corp., West Haven, CT. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19537s049,19857s031,19847se5-027,20780se5-013_cipro_lbl.pdf

  9. Gough A, Barsoum NJ, Mitchell L, McGuire EJ, de la Iglesia FA (1979) Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 51:177–187

    Article  CAS  PubMed  Google Scholar 

  10. Committee on Infectious Diseases (2006) The use of systemic fluoroquinolones. Pediatrics 118:1287–1292

    Article  Google Scholar 

  11. Batchoun RG, Swedan SF, Shurman AM (2009) Extended spectrum beta-lactamases among Gram-negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan. Int J Microbiol 2009:513874

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orli Megged.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Megged, O. Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol 29, 1583–1587 (2014). https://doi.org/10.1007/s00467-014-2810-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-014-2810-y

Keywords

Navigation